Literature DB >> 25294091

Subclinical inflammation with tocilizumab treatment of rheumatoid arthritis: MRI evaluation for 2 years.

Takeshi Suzuki1, Tomoya Hirota, Hiroshi Ogishima, Naoto Umeda, Yuya Kondo, Masahiro Yokosawa, Haruka Miki, Hiroto Tsuboi, Isao Matsumoto, Takayuki Sumida.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25294091     DOI： 10.1111/1756-185X.12460

Source DB:  PubMed          Journal:  Int J Rheum Dis        ISSN： 1756-1841            Impact factor:   2.454


× No keyword cloud information.
  2 in total

1.  The application value of MRI in the diagnosis of subclinical inflammation in patients with rheumatoid arthritis in remission.

Authors:  Huimei Zhang; Huajun Xu; Shifang Chen; Xinfeng Mao
Journal:  J Orthop Surg Res       Date:  2018-07-03       Impact factor: 2.359

2.  Ultrasound is more reliable than inflammatory parameters to evaluate disease activity in patients with RA receiving tocilizumab therapy.

Authors:  Wen-Chan Chiu; Han-Ming Lai; Chi-Hua Ko; Jia-Feng Chen; Chung-Yuan Hsu; Ying-Chou Chen
Journal:  J Investig Med       Date:  2018-03-25       Impact factor: 2.895
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.